ebomi
Colour theme
Sign in
Insider · CIK 0001779308

Yale Catriona

CIK 0001779308 Name as filed on the most recent filing

Filed as Yale Catriona (40)

73 transaction lines · from 40 filings · filed 2021-07-19 to 2025-09-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

73 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-09-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 659 disposed 43.02 28,350.18 Form 4, filing 0000950170-25-114665
2025-07-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,658 disposed 52.86 457,705.17 Form 4, filing 0000950170-25-097013
2025-07-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,342 disposed 53.47 71,762.11 Form 4, filing 0000950170-25-097013
2025-06-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,633 disposed 54.84 89,553.72 Form 4, filing 0000950170-25-088636
2025-06-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,210 disposed 53.78 333,973.80 Form 4, filing 0000950170-25-088207
2025-06-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,895 disposed 54.80 158,643.10 Form 4, filing 0000950170-25-088207
2025-06-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 895 disposed 55.52 49,689.50 Form 4, filing 0000950170-25-088207
2025-06-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,803 disposed 54.00 151,350.79 Form 4, filing 0000950170-25-085671
2025-05-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 4,384 disposed 39.91 174,947.90 Form 4, filing 0000950170-25-074708
2025-05-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,837 disposed 38.20 108,370.56 Form 4, filing 0000950170-25-074708
2025-05-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,779 disposed 39.46 109,659.34 Form 4, filing 0000950170-25-074708
2025-04-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,873 disposed 37.80 297,623.02 Form 4, filing 0000950170-25-054893
2025-04-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,200 disposed 38.62 46,339.20 Form 4, filing 0000950170-25-054893
2025-03-17 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,201 disposed 44.70 366,560.10 Form 4, filing 0000950170-25-041458
2025-03-17 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,799 disposed 45.05 81,044.95 Form 4, filing 0000950170-25-041458
2025-03-12 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 614 disposed 44.88 27,556.32 Form 4, filing 0000950170-25-039736
2025-02-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 9,100 disposed 49.79 453,089.00 Form 4, filing 0000950170-25-024996
2025-02-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 900 disposed 50.63 45,570.60 Form 4, filing 0000950170-25-024996
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 25,907 disposed 55.15 1,428,822.86 Form 4, filing 0000950170-25-011444
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,467 disposed 55.95 809,428.65 Form 4, filing 0000950170-25-011444
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,700 disposed 57.01 495,960.90 Form 4, filing 0000950170-25-011444
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 27,340 disposed 57.02 1,559,036.16 Form 4, filing 0000950170-25-011445
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 17,000 disposed 55.16 937,652.00 Form 4, filing 0000950170-25-011445
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 9,250 disposed 55.95 517,528.25 Form 4, filing 0000950170-25-011445
2024-12-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 9,074 disposed 29.11 264,116.92 Form 4, filing 0000950170-24-138146
2024-12-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,810 disposed 30.79 86,519.90 Form 4, filing 0000950170-24-136019
2024-11-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,761 disposed 27.69 242,627.13 Form 4, filing 0000950170-24-128994
2024-11-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 300 disposed 28.82 8,646.90 Form 4, filing 0000950170-24-128994
2024-11-06 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 10,000 disposed 35.19 351,890.00 Form 4, filing 0000950170-24-124230
2024-11-01 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 15,485 disposed 32.62 505,105.22 Form 4, filing 0000950170-24-120231
2024-10-30 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 4,515 disposed 32.53 146,854.89 Form 4, filing 0000950170-24-120231
2024-10-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,525 disposed 30.50 442,954.40 Form 4, filing 0000950170-24-115138
2024-10-15 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 300 disposed 30.93 9,278.10 Form 4, filing 0000950170-24-115138
2024-10-14 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,136 disposed 30.03 184,257.94 Form 4, filing 0000950170-24-115138
2024-09-20 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 5,500 disposed 27.65 152,086.00 Form 4, filing 0000950170-24-108837
2024-09-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 3,871 disposed 27.56 106,684.76 Form 4, filing 0000950170-24-107969
2024-09-17 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,037 disposed 27.55 56,115.28 Form 4, filing 0000950170-24-107969
2024-09-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,485 disposed 27.52 68,374.78 Form 4, filing 0000950170-24-107969
2024-09-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 637 disposed 26.18 16,676.66 Form 4, filing 0000950170-24-106470
2024-09-03 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 949 disposed 27.61 26,205.69 Form 4, filing 0000950170-24-103977
2024-08-26 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 5,200 disposed 27.51 143,072.80 Form 4, filing 0000950170-24-101257
2024-08-23 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,851 disposed 27.53 243,641.48 Form 4, filing 0000950170-24-101257
2024-06-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,825 disposed 22.64 63,960.82 Form 4, filing 0000950170-24-073190
2024-03-13 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 723 disposed 28.33 20,482.59 Form 4, filing 0000950170-24-032266
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 20,646 disposed 35.49 732,726.54 Form 4, filing 0000950170-24-027509
2023-12-14 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 597 disposed 20.76 12,393.72 Form 4, filing 0000950170-23-071250
2023-09-21 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,800 disposed 47.85 133,969.08 Form 4, filing 0000950170-23-049765
2023-09-21 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,200 disposed 48.36 106,386.94 Form 4, filing 0000950170-23-049765
2023-09-13 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 617 disposed 50.34 31,059.78 Form 4, filing 0000950170-23-049765
2023-08-28 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 5,245 disposed 49.92 261,855.58 Form 4, filing 0000950170-23-045549

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 73
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Yale Catriona, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001779308

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.